高剂量8毫克阿弗利伯塞普特用于神经血管与年龄相关的黄斑退化:谁正在使用这个新药物治疗?
Caspar Liesenhoff1, Carolin Meyrl1, Daniel Krause1
1Department of Ophthalmology, Ludwig-Maximilians-University, Mathildenstrasse 8, 80336 Munich, Germany.
Life (Basel, Switzerland)
|November 27, 2025
概括
高剂量的8毫克阿弗利伯塞普特被用作新血管与年龄相关的黄斑变性 (nAMD) 的交换疗法. 主要原因包括尽管经常服用剂量或延长治疗间隔,但仍然存在持续的液体.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经血管与年龄相关的黄斑变性 (nAMD) 是导致视力丧失的主要原因.
- 抗血管内皮生长因子 (VEGF) 疗法是标准的治疗方法.
- 高剂量的aflibercept (8毫克) 在nAMD管理中提供了潜在的进步.
研究的目的:
- 确定在nAMD患者中使用高剂量8毫克aflibercept的指示.
- 分析来自第三级推中心的真实世界队列数据.
主要方法:
- 对接受8毫克aflibercept治疗的nAMD患者的回顾性分析.
- 数据收集包括人口统计,成像和治疗参数.
- 分析了转换为8毫克aflibercept的原因.
主要成果:
- 来自31名患者的34只眼睛接受了8毫克aflibercept,仅作为交换疗法.
- 大多数患者 (76%) 从2毫克aflibercept.com转换.
- 转换的主要原因是反抗性nAMD与持久性流体 (50%) 和希望更长的治疗间隔 (44%).
结论:
- 高剂量的8毫克阿弗利伯塞普特被用作nAMD的交换疗法.
- 反复性疾病和延长剂量间隔是关键的适应症.
- 这些发现将为未来的现实世界研究提供信息,将8毫克阿弗利塞普特与其他治疗方法进行比较.
更多相关视频
08:54Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
2.1K
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.4K
相关概念视频
01:27Open Angle Glaucoma: Treatment
938
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
938
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772